Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt repayments

Daily Values

Growth Metrics

Alkami Technology (ALKT) Asset Writedowns and Impairment (2025)

Alkami Technology (ALKT) has disclosed Asset Writedowns and Impairment for 1 consecutive years, with $1.7 million as the latest value for Q1 2025.

For Q1 2025, Asset Writedowns and Impairment changed N/A year-over-year to $1.7 million; the TTM value through Dec 2025 reached $1.7 million, changed N/A, while the annual FY2025 figure was $1.7 million, N/A changed from the prior year.
Asset Writedowns and Impairment hit $1.7 million in Q1 2025 for Alkami Technology.
Across five years, Asset Writedowns and Impairment topped out at $1.7 million in Q1 2025 and bottomed at $1.7 million in Q1 2025.